166 related articles for article (PubMed ID: 9126676)
1. Nisoldipine CC: efficacy and tolerability in hypertension and ischemic heart disease.
Fodor JG
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():873-9. PubMed ID: 9126676
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
3. Nisoldipine coat-core. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of ischaemic heart disease.
Langtry HD; Spencer CM
Drugs; 1997 May; 53(5):867-84. PubMed ID: 9129871
[TBL] [Abstract][Full Text] [Related]
4. Nisoldipine coat-core and heart rate response during treatment of hypertension.
Zannad F
Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
[TBL] [Abstract][Full Text] [Related]
5. Rapid-release and coat-core formulations of nisoldipine in treatment of hypertension, angina, and heart failure.
Hamilton SF; Houle LM; Thadani U
Heart Dis; 1999; 1(5):279-88. PubMed ID: 11720635
[TBL] [Abstract][Full Text] [Related]
6. Antianginal and antiischemic efficacy of monotherapy extended-release nisoldipine (Coat Core) in chronic stable angina.
Glasser SP; Ripa S; Garland WT; Weiss R; Nademanee K; Singh S; Bittar N
J Clin Pharmacol; 1995 Aug; 35(8):780-4. PubMed ID: 8522634
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
White WB
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
[TBL] [Abstract][Full Text] [Related]
8. Nisoldipine CC: clinical experience in ischaemic heart disease.
Melcher A; Dens J; Curry P; Hagel H
Cardiology; 1997; 88 Suppl 1():17-23; discussion 24-5. PubMed ID: 9118164
[TBL] [Abstract][Full Text] [Related]
9. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
Ruddy TD; Fodor JG
Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nisoldipine coat core in the management of angina pectoris, systemic hypertension, and ischemic ventricular dysfunction.
Lewis BS
Am J Cardiol; 1995 Apr; 75(13):46E-53E. PubMed ID: 7726125
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive monotherapy with nisoldipine CC is superior to enalapril in black patients with severe hypertension.
Radevski I; Skudicky D; Candy G; Sathekge S; Strugo V; Sareli P
Am J Hypertens; 1999 Feb; 12(2 Pt 1):194-203. PubMed ID: 10090348
[TBL] [Abstract][Full Text] [Related]
12. Nisoldipine CC: clinical experience in hypertension.
Langan J; Rodríguez-Mañas L; Sareli P; Heinig R
Cardiology; 1997; 88 Suppl 1():56-62; discussion 63-5. PubMed ID: 9118169
[TBL] [Abstract][Full Text] [Related]
13. Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension.
Plosker GL; Faulds D
Drugs; 1996 Aug; 52(2):232-53. PubMed ID: 8841741
[TBL] [Abstract][Full Text] [Related]
14. What does nisoldipine coat core (CC) add to current therapy that is clinically meaningful?
Opie LH
Am J Cardiol; 1997 May; 79(10A):29-32; discussion 47-8. PubMed ID: 9186064
[TBL] [Abstract][Full Text] [Related]
15. Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
Pepine CJ; Cooper-DeHoff RM; Weiss RJ; Koren M; Bittar N; Thadani U; Minkwitz MC; Michelson EL; Hutchinson HG;
Am J Cardiol; 2003 Feb; 91(3):274-9. PubMed ID: 12565082
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
[TBL] [Abstract][Full Text] [Related]
17. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Friedel HA; Sorkin EM
Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
[TBL] [Abstract][Full Text] [Related]
18. Antianginal and anti-ischemic efficacy of immediate-release nisoldipine in chronic stable angina pectoris.
Glasser SP; Bittar N; Labreche DG; Singh B; Katz R; Schulman P
Am J Cardiol; 1994 Jun; 73(16):1165-8. PubMed ID: 7911271
[TBL] [Abstract][Full Text] [Related]
19. Nisoldipine--a new calcium channel blocker for hypertension.
Med Lett Drugs Ther; 1996 Feb; 38(968):13-4. PubMed ID: 8592476
[TBL] [Abstract][Full Text] [Related]
20. DEFIANT-II: a study of nisoldipine CC after myocardial infarction. Doppler flow and Echocardiography in Functional cardiac Insufficiency: Assessment of Nisoldipine Therapy investigators.
Hall R
Cardiovasc Drugs Ther; 1997 Jan; 10 Suppl 3():881. PubMed ID: 9126677
[No Abstract] [Full Text] [Related]
[Next] [New Search]
